MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy
2025 · Cancer Gene Therapy · 37 citations
https://doi.org/10.1038/s41417-025-00886-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
79
Citations
4
h-index
2
i10-index
Abdulrahman Ibrahim is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Migration, Health and Trauma & Liver Disease Diagnosis and Treatment. The author has an h-index of 4, co-authored 9 publications.
ORCID: 0009-0003-9153-9764https://doi.org/10.1038/s41417-025-00886-9
https://doi.org/10.3390/cells14020108
Click to start Chat